• Explore /
  • Poster
  • / Open-label, dose-escalation, phase 1 study of venetoclax in combination with navitoclax and chemotherapy in patients with relapsed acute lymphoblastic leukemia.

Open-label, dose-escalation, phase 1 study of venetoclax in combination with navitoclax and chemotherapy in patients with relapsed acute lymphoblastic leukemia.

Abstract Poster

Authors

null

Thomas Alexander

Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, NC

Thomas Alexander , Seong Lin Khaw , Jeffrey E. Rubnitz , Susan I. Vear , Norman James Lacayo , Michelle Schmidt , Bo Tong , Lindsey Rosenwinkel , Lindsey Bensman , Maria Verdugo , Su Young Kim , Elias Jabbour , Wendy Stock

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Leukemia/Lymphoma

Clinical Trial Registration Number

NCT03181126

Citation

J Clin Oncol 36, 2018 (suppl; abstr TPS10575)

DOI

10.1200/JCO.2018.36.15_suppl.TPS10575

Abstract #

TPS10575

Poster Bd #

248a

Abstract Disclosures

Similar Posters

First Author: Julio C. Barredo

First Author: Laura Agresta

First Author: Orlando Bueno

First Author: Kelly W. Maloney